SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-065229
Filing Date
2024-05-28
Accepted
2024-05-28 16:17:51
Documents
13
Period of Report
2024-05-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K evok-20240522.htm   iXBRL 8-K 99291
2 EX-3.1 evok-ex3_1.htm EX-3.1 18331
3 EX-10.1 evok-ex10_1.htm EX-10.1 631
  Complete submission text file 0000950170-24-065229.txt   238322

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT evok-20240522.xsd EX-101.SCH 24864
16 EXTRACTED XBRL INSTANCE DOCUMENT evok-20240522_htm.xml XML 4715
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 24992099
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)